Rajeshwari Nagaraja, MD
Family Practice · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 5 carriers
- Office
- 1
Offices
1 location · One Medical Group Inc · 330 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
19 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nagaraja’s office at (888) 663-6331 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A147104 · Current
Licensed to practise in California · since 2017 · expires 2027-01-31 · Rajiv Gandhi University of Health Sciences, Dr. B.R. Ambedkar Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$5,286
Medicare paid this office $5,286 for 63 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 37 | $2,751 | $69 |
| Insertion of needle into vein for collection of blood sample | 15 | $130 | $9 |
Who their Medicare patients are
63 Original Medicare patients in 2024. Average age 73 · Women 65% · Health risk score 0.94. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 52% · Depression 29% · Chronic kidney disease 19%.
The office billed $40,511, Medicare allowed $8,338 and paid $5,286; for 98 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 63 | 98 | 73 | 0.94 | $40,511 | $5,286 |
| 2021 | 18 | 27 | 74 | 0.70 | $9,180 | $2,019 |
| 2019 | 31 | 81 | 64 | 1.14 | $1,972 | $922 |
| 2018 | 52 | 129 | 60 | 1.34 | $3,267 | $1,637 |
| 2017 | 66 | 114 | 69 | 1.32 | $8,884 | $1,554 |
| 2016 | 278 | 1,516 | 68 | 1.42 | $127,265 | $60,487 |
| 2015 | 317 | 1,775 | 69 | 1.26 | $127,719 | $63,942 |
| 2014 | 203 | 513 | 70 | 1.29 | $46,058 | $24,299 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2018: 3 services
| Blood test, comprehensive group of blood chemicals | 20 | $268 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 24 | $235 | $9 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $194 | $16 |
2017: 3 services
| Return visit (30+ min) | 33 | $768 | $21 |
| Short return visit (20+ min) | 20 | $167 | $8 |
| Insertion of needle into vein for collection of blood sample | 19 | $65 | $3 |
2016: 16 services
| Return visit (30+ min) | 179 | $21,582 | $70 |
| Short return visit (20+ min) | 145 | $12,933 | $43 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $5,731 | $106 |
| Test for balance and posture | 49 | $3,487 | $71 |
| Neuropsychological testing by technician with interpretation and report by a qualified healthcare professional per hour | 54 | $2,857 | $53 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 34 | $1,666 | $30 |
| Psychological testing with interpretation and report by computer | 79 | $1,434 | $18 |
| Administration of influenza virus vaccine | 50 | $1,194 | $23 |
| New patient visit (30+ min) | 18 | $976 | $54 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 36 | $891 | $25 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 49 | $794 | $16 |
| Injection of drug or substance under skin or into muscle | 23 | $635 | $16 |
| Insertion of needle into vein for collection of blood sample | 109 | $582 | $3 |
| Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes | 15 | $207 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $165 | $12 |
| Urinalysis, manual test | 20 | $78 | $3 |
2015: 14 services
| Short return visit (20+ min) | 175 | $17,615 | $48 |
| Return visit (30+ min) | 144 | $15,752 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 81 | $8,954 | $111 |
| Transitional care management services for problem of high complexity | 17 | $2,975 | $175 |
| Short return visit | 40 | $2,456 | $30 |
| Administration of influenza virus vaccine | 71 | $1,668 | $23 |
| New patient visit (45+ min) | 15 | $1,417 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,010 | $56 |
| Insertion of needle into vein for collection of blood sample | 128 | $750 | $3 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 43 | $651 | $15 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 28 | $356 | $13 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 11 | $252 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $243 | $12 |
| Urinalysis, manual test | 20 | $78 | $3 |
2014: 7 services
| Short return visit (20+ min) | 102 | $6,620 | $52 |
| Return visit (30+ min) | 63 | $6,178 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,092 | $107 |
| Short return visit | 27 | $1,033 | $32 |
| Administration of influenza virus vaccine | 23 | $533 | $23 |
| Insertion of needle into vein for collection of blood sample | 58 | $209 | $3 |
| Urinalysis, manual test | 20 | $72 | $3 |
Medicaid work
$194,252 in 2023
Medicaid paid $194,252 for 2,408 billed services this clinician did in 2023, up to 193 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 906 | $192,103 |
| Short return visit (20+ min) | 1,158 | $1,725 |
| Return visit (30+ min) | 99 | $290 |
| Short return visit | 221 | $134 |
| Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 24 | $0 |
| 2023 | 2,408 | 5 | 193 | $194,252 |
| 2022 | 2,655 | 6 | 128 | $210,193 |
| 2021 | 917 | 10 | 46 | $72 |
| 2020 | 1,244 | 9 | 76 | $75 |
| 2019 | 2,073 | 15 | 91 | $264 |
| 2018 | 2,621 | 17 | 101 | $32 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 1,039 | $209,684 |
| Short return visit | 457 | $239 |
| Short return visit (20+ min) | 973 | $236 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 71 | $34 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 73 | $0 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 42 | $0 |
2021
| Short return visit (20+ min) | 235 | $72 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 142 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 107 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 31 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 26 | $0 |
| Hemoglobin A1C level | 51 | $0 |
| Thyroid stimulating hormone (TSH) | 16 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 15 | $0 |
| Short return visit | 156 | $0 |
| Return visit (30+ min) | 138 | $0 |
2020
| Return visit (30+ min) | 243 | $75 |
| COMPREHENSIVE METABOLIC PANEL | 120 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 40 | $0 |
| Hemoglobin A1C level | 65 | $0 |
| Thyroid stimulating hormone (TSH) | 12 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 14 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $0 |
| Short return visit | 92 | $0 |
| Short return visit (20+ min) | 646 | $0 |
2019
| Short return visit (20+ min) | 944 | $215 |
| COMPREHENSIVE METABOLIC PANEL | 132 | $37 |
| Blood test, lipids (cholesterol and triglycerides) | 71 | $12 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 12 | $0 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 36 | $0 |
| URINE PREGNANCY TEST | 118 | $0 |
| Hemoglobin A1C level | 145 | $0 |
| Thyroid stimulating hormone (TSH) | 32 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 31 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 94 | $0 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 29 | $0 |
| MEASURE BLOOD OXYGEN LEVEL | 35 | $0 |
2018
| COMPREHENSIVE METABOLIC PANEL | 236 | $18 |
| Hemoglobin A1C level | 171 | $8 |
| Blood test, lipids (cholesterol and triglycerides) | 177 | $5 |
| URINE PREGNANCY TEST | 82 | $0 |
| Thyroid stimulating hormone (TSH) | 127 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 66 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 152 | $0 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 28 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $0 |
| MEASURE BLOOD OXYGEN LEVEL | 41 | $0 |
| Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument | 56 | $0 |
| Bilateral quantitative screening test of visual acuity | 12 | $0 |
Drugs they prescribed that Part D paid
$4,703
Pharmacies billed $4,703 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
107 generic and fewer than 11 brand-name prescriptions · $4,703 in drug cost · 12 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atenolol | 22 | $96 | $4 |
Year by year
| 2024 | 123 | 67 | None | None | $4,703 |
| 2023 | 1,388 | 205 | 1% (13) | None | $191,908 |
| 2022 | 950 | 185 | 3% (29) | 15% | $102,348 |
| 2021 | 802 | 88 | None | 18% | $72,189 |
| 2020 | 1,059 | 110 | None | None | $77,418 |
| 2019 | 1,286 | 137 | None | None | $53,655 |
| 2018 | 1,329 | 117 | 2% (27) | 14% | $67,860 |
| 2017 | 1,022 | 221 | 4% (43) | 22% | $82,065 |
| 2016 | 3,972 | 337 | 5% (210) | 21% | $378,882 |
| 2015 | 3,085 | 317 | 7% (212) | 21% | $247,460 |
| 2014 | 1,093 | 239 | 9% (95) | 25% | $76,519 |
| 2013 | 574 | 53 | 2% (14) | 28% | $63,485 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Trulicity | 39 | $41,842 | $1,073 |
| Jardiance | 20 | $32,486 | $1,624 |
| Tradjenta | 20 | $31,129 | $1,556 |
| Advair Diskus | 13 | $6,454 | $496 |
| Atorvastatin | 128 | $2,470 | $19 |
| Amlodipine Besylate | 86 | $1,299 | $15 |
| Metformin | 78 | $1,004 | $13 |
| Losartan | 51 | $878 | $17 |
| Levothyroxine | 38 | $872 | $23 |
| Omeprazole | 48 | $865 | $18 |
| Lisinopril | 57 | $843 | $15 |
| Fenofibrate | 13 | $704 | $54 |
| Albuterol Sulfate Hfa | 22 | $701 | $32 |
| Pravastatin | 30 | $597 | $20 |
| Tamsulosin | 17 | $510 | $30 |
| Glipizide | 29 | $418 | $14 |
| Metoprolol | 16 | $404 | $25 |
| Sertraline | 23 | $389 | $17 |
| Gabapentin | 24 | $367 | $15 |
| Alendronate | 21 | $359 | $17 |
| Montelukast | 13 | $315 | $24 |
| Fluticasone Propionate | 20 | $291 | $15 |
| Famotidine | 13 | $281 | $22 |
| Diclofenac | 16 | $266 | $17 |
| Pregabalin | 13 | $206 | $16 |
| Metoprolol | 16 | $205 | $13 |
| Furosemide | 19 | $190 | $10 |
| Benazepril | 16 | $170 | $11 |
| Hydrochlorothiazide | 23 | $168 | $7 |
| Metformin Hcl Er | 14 | $146 | $10 |
| Atenolol | 20 | $134 | $7 |
2022: 20 drugs
| Trulicity | 18 | $18,347 | $1,019 |
| Tradjenta | 14 | $13,856 | $990 |
| Lantus Solostar | 13 | $4,109 | $316 |
| Atorvastatin | 79 | $1,007 | $13 |
| Albuterol Sulfate Hfa | 25 | $869 | $35 |
| Levothyroxine | 32 | $641 | $20 |
| Metformin | 57 | $575 | $10 |
| Diclofenac | 17 | $506 | $30 |
| Amlodipine Besylate | 56 | $460 | $8 |
| Omeprazole | 34 | $413 | $12 |
| Losartan | 30 | $336 | $11 |
| Gabapentin | 23 | $263 | $11 |
| Metoprolol | 21 | $223 | $11 |
| Lisinopril | 41 | $215 | $5 |
| Famotidine | 19 | $191 | $10 |
| Glipizide | 18 | $172 | $10 |
| Fluticasone Propionate | 12 | $167 | $14 |
| Hydrochlorothiazide | 16 | $115 | $7 |
| Ibuprofen | 11 | $81 | $7 |
| Furosemide | 14 | $64 | $5 |
2021: 17 drugs
| Trulicity | 20 | $20,835 | $1,042 |
| Basaglar Kwikpen U-100 | 15 | $6,494 | $433 |
| Atorvastatin | 113 | $1,235 | $11 |
| Albuterol Sulfate Hfa | 25 | $1,079 | $43 |
| Gabapentin | 32 | $335 | $10 |
| Levothyroxine | 16 | $326 | $20 |
| Lisinopril | 71 | $249 | $4 |
| Metformin | 54 | $201 | $4 |
| Amlodipine Besylate | 46 | $199 | $4 |
| Losartan | 18 | $161 | $9 |
| Famotidine | 20 | $126 | $6 |
| Fluticasone Propionate | 11 | $104 | $9 |
| Carvedilol | 18 | $93 | $5 |
| Hydralazine | 13 | $86 | $7 |
| Hydrochlorothiazide | 23 | $81 | $4 |
| Furosemide | 15 | $78 | $5 |
| Fluoxetine | 20 | $68 | $3 |
2020: 24 drugs
| Tradjenta | 13 | $8,018 | $617 |
| Incruse Ellipta | 12 | $4,028 | $336 |
| Albuterol Sulfate Hfa | 39 | $1,577 | $40 |
| Atorvastatin | 137 | $1,537 | $11 |
| Levothyroxine | 26 | $532 | $20 |
| Lisinopril | 92 | $481 | $5 |
| Sertraline | 30 | $377 | $13 |
| Amlodipine Besylate | 69 | $345 | $5 |
| Metformin | 67 | $264 | $4 |
| Losartan | 25 | $235 | $9 |
| Fluticasone Propionate | 15 | $172 | $11 |
| Carvedilol | 25 | $169 | $7 |
| Furosemide | 23 | $161 | $7 |
| Famotidine | 17 | $152 | $9 |
| Gabapentin | 24 | $142 | $6 |
| Montelukast | 13 | $129 | $10 |
| Hydrochlorothiazide | 32 | $127 | $4 |
| Metoprolol | 24 | $114 | $5 |
| Omeprazole | 11 | $94 | $9 |
| Alendronate | 18 | $87 | $5 |
| Atenolol | 14 | $82 | $6 |
| Donepezil | 12 | $81 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $72 | $6 |
| Glipizide | 12 | $42 | $4 |
2019: 32 drugs
| Atorvastatin | 168 | $1,663 | $10 |
| Colchicine | 11 | $1,393 | $127 |
| Ventolin Hfa | 13 | $729 | $56 |
| Levothyroxine | 36 | $655 | $18 |
| Oxybutynin Chloride | 16 | $604 | $38 |
| Lisinopril | 116 | $603 | $5 |
| Tolterodine | 11 | $592 | $54 |
| Albuterol Sulfate Hfa | 14 | $502 | $36 |
| Triamcinolone Acetonide | 14 | $495 | $35 |
| Losartan | 28 | $376 | $13 |
| Amlodipine Besylate | 101 | $373 | $4 |
| Potassium Chloride | 18 | $288 | $16 |
| Gabapentin | 31 | $279 | $9 |
| Hydralazine | 11 | $234 | $21 |
| Sertraline | 24 | $231 | $10 |
| Metformin | 52 | $229 | $4 |
| Fluticasone Propionate | 17 | $216 | $13 |
| Carvedilol | 32 | $206 | $6 |
| Hydrochlorothiazide | 41 | $170 | $4 |
| Doxazosin Mesylate | 14 | $168 | $12 |
| Metoprolol | 31 | $166 | $5 |
| Furosemide | 31 | $152 | $5 |
| Ranitidine | 19 | $142 | $7 |
| Atenolol | 22 | $94 | $4 |
| Famotidine | 14 | $82 | $6 |
| Hydrocortisone | 12 | $68 | $6 |
| Donepezil | 15 | $67 | $4 |
| Hydroxyzine | 12 | $59 | $5 |
| Glipizide | 13 | $59 | $5 |
| Trazodone | 14 | $54 | $4 |
| Terazosin | 11 | $53 | $5 |
| Alendronate | 12 | $44 | $4 |
2018: 31 drugs
| Januvia | 30 | $15,017 | $501 |
| Combivent Respimat | 11 | $4,123 | $375 |
| Colchicine | 11 | $1,635 | $149 |
| Ventolin Hfa | 25 | $1,372 | $55 |
| Atorvastatin | 156 | $1,163 | $7 |
| Lisinopril | 121 | $534 | $4 |
| Gabapentin | 38 | $416 | $11 |
| Levothyroxine | 20 | $392 | $20 |
| Bupropion Hcl Sr | 14 | $374 | $27 |
| Amlodipine Besylate | 85 | $330 | $4 |
| Montelukast | 21 | $298 | $14 |
| Metformin | 61 | $292 | $5 |
| Carvedilol | 37 | $204 | $6 |
| Triamcinolone Acetonide | 15 | $197 | $13 |
| Allopurinol | 13 | $188 | $14 |
| Glipizide | 32 | $184 | $6 |
| Losartan | 17 | $159 | $9 |
| Hydralazine | 12 | $154 | $13 |
| Lisinopril-Hydrochlorothiazide | 24 | $147 | $6 |
| Hydrochlorothiazide | 38 | $145 | $4 |
| Ranitidine | 22 | $137 | $6 |
| Pantoprazole | 23 | $132 | $6 |
| Omeprazole | 16 | $103 | $6 |
| Clopidogrel | 20 | $96 | $5 |
| Hydrocodone-Acetaminophen | 11 | $89 | $8 |
| Metoprolol | 21 | $76 | $4 |
| Sertraline | 19 | $69 | $4 |
| Atenolol | 15 | $63 | $4 |
| Alendronate | 12 | $56 | $5 |
| Furosemide | 11 | $48 | $4 |
| Simvastatin | 12 | $32 | $3 |
2017: 21 drugs
| Januvia | 19 | $10,189 | $536 |
| Lantus | 12 | $4,114 | $343 |
| Potassium Chloride | 24 | $1,240 | $52 |
| Atorvastatin | 60 | $886 | $15 |
| Ventolin Hfa | 11 | $579 | $53 |
| Levothyroxine | 25 | $443 | $18 |
| Lisinopril | 59 | $306 | $5 |
| Simvastatin | 29 | $286 | $10 |
| Montelukast | 16 | $262 | $16 |
| Omeprazole | 28 | $234 | $8 |
| Pantoprazole | 11 | $231 | $21 |
| Metformin | 37 | $167 | $5 |
| Gabapentin | 17 | $162 | $10 |
| Hydrocodone-Acetaminophen | 12 | $154 | $13 |
| Tramadol | 21 | $101 | $5 |
| Amlodipine Besylate | 28 | $99 | $4 |
| Metoprolol | 24 | $99 | $4 |
| Furosemide | 21 | $91 | $4 |
| Glipizide | 18 | $91 | $5 |
| Bupropion Hcl Sr | 12 | $86 | $7 |
| Meloxicam | 13 | $71 | $5 |
2016: 89 drugs
| Lantus Solostar | 44 | $36,162 | $822 |
| Januvia | 25 | $18,271 | $731 |
| Spiriva | 24 | $16,867 | $703 |
| Lyrica | 20 | $15,789 | $789 |
| Zetia | 19 | $14,458 | $761 |
| Symbicort | 25 | $9,428 | $377 |
| Advair Diskus | 14 | $9,071 | $648 |
| Vytorin | 11 | $7,945 | $722 |
| Levemir Flextouch | 15 | $6,434 | $429 |
| Celecoxib | 18 | $6,261 | $348 |
| Memantine | 12 | $4,848 | $404 |
| Effient | 11 | $4,191 | $381 |
| Potassium Chloride | 88 | $3,420 | $39 |
| Atorvastatin | 186 | $2,792 | $15 |
| Ventolin Hfa | 37 | $2,199 | $59 |
| Toprol Xl | 27 | $2,100 | $78 |
| Levothyroxine | 100 | $1,984 | $20 |
| Proair Hfa | 30 | $1,972 | $66 |
| Simvastatin | 128 | $1,843 | $14 |
| Gabapentin | 75 | $1,544 | $21 |
| Chlorthalidone | 27 | $1,522 | $56 |
| Theophylline Anhydrous | 11 | $1,461 | $133 |
| Bd Ultra-Fine Pen Needle | 23 | $1,429 | $62 |
| Oxybutynin Chloride | 35 | $1,375 | $39 |
| Lisinopril | 221 | $1,253 | $6 |
| Hydrocodone-Acetaminophen | 68 | $1,163 | $17 |
| Methotrexate | 12 | $1,140 | $95 |
| Tamsulosin | 35 | $1,123 | $32 |
| Pravastatin | 62 | $1,119 | $18 |
| Metoprolol | 39 | $1,064 | $27 |
| Bumetanide | 20 | $1,032 | $52 |
| Omeprazole | 94 | $990 | $11 |
| Amlodipine Besylate | 96 | $906 | $9 |
| Venlafaxine Hcl Er | 14 | $831 | $59 |
| Synthroid | 56 | $789 | $14 |
| Warfarin | 53 | $778 | $15 |
| Verapamil Er | 16 | $770 | $48 |
| Montelukast | 34 | $709 | $21 |
| Levetiracetam | 28 | $690 | $25 |
| Clopidogrel | 30 | $665 | $22 |
| Tramadol | 102 | $546 | $5 |
| Isosorbide Mononitrate Er | 31 | $539 | $17 |
| Metoprolol | 118 | $521 | $4 |
| Hydralazine | 26 | $504 | $19 |
| Losartan-Hydrochlorothiazide | 14 | $495 | $35 |
| Acetaminophen-Codeine | 30 | $489 | $16 |
| Propranolol | 20 | $486 | $24 |
| Valsartan-Hydrochlorothiazide | 18 | $472 | $26 |
| Losartan | 29 | $468 | $16 |
| Doxazosin Mesylate | 14 | $441 | $32 |
| Duloxetine | 11 | $413 | $38 |
| Sertraline | 34 | $413 | $12 |
| Metformin | 112 | $412 | $4 |
| Bupropion Xl | 14 | $380 | $27 |
| Furosemide | 105 | $373 | $4 |
| Pantoprazole | 25 | $355 | $14 |
| Cartia Xt | 13 | $340 | $26 |
| Ranitidine | 19 | $323 | $17 |
| Lorazepam | 33 | $318 | $10 |
| Allopurinol | 15 | $316 | $21 |
| Clotrimazole-Betamethasone | 11 | $264 | $24 |
| Fluticasone Propionate | 27 | $263 | $10 |
| Trazodone | 22 | $230 | $10 |
| Lisinopril-Hydrochlorothiazide | 42 | $191 | $5 |
| Triamterene-Hydrochlorothiazid | 18 | $191 | $11 |
| Hydrochlorothiazide | 44 | $183 | $4 |
| Citalopram Hbr | 25 | $176 | $7 |
| Meloxicam | 31 | $173 | $6 |
| Cyclobenzaprine | 18 | $171 | $10 |
| Paroxetine | 26 | $170 | $7 |
| Famotidine | 14 | $166 | $12 |
| Atenolol | 25 | $166 | $7 |
| Carvedilol | 17 | $153 | $9 |
| Ropinirole | 12 | $148 | $12 |
| Alendronate | 19 | $147 | $8 |
| Glipizide | 33 | $144 | $4 |
| Alprazolam | 38 | $137 | $4 |
| Clonazepam | 13 | $134 | $10 |
| Prednisone | 32 | $99 | $3 |
| Buspirone | 14 | $93 | $7 |
| Temazepam | 15 | $87 | $6 |
| Donepezil | 17 | $86 | $5 |
| Azithromycin | 13 | $85 | $7 |
| Naproxen | 15 | $69 | $5 |
| Ciprofloxacin | 11 | $61 | $6 |
| Cephalexin | 22 | $59 | $3 |
| Diazepam | 11 | $44 | $4 |
| Hydroxyzine Pamoate | 12 | $44 | $4 |
| Zolpidem | 11 | $33 | $3 |
2015: 76 drugs
| Lantus Solostar | 31 | $27,565 | $889 |
| Lyrica | 24 | $12,131 | $505 |
| Levemir Flextouch | 16 | $10,848 | $678 |
| Spiriva | 23 | $10,435 | $454 |
| Advair Diskus | 16 | $10,283 | $643 |
| Januvia | 13 | $9,863 | $759 |
| Combivent Respimat | 13 | $9,362 | $720 |
| Symbicort | 24 | $8,082 | $337 |
| Celecoxib | 16 | $3,629 | $227 |
| Atorvastatin | 116 | $2,036 | $18 |
| Levothyroxine | 75 | $1,789 | $24 |
| Potassium Chloride | 60 | $1,704 | $28 |
| Gabapentin | 59 | $1,584 | $27 |
| Proair Hfa | 21 | $1,576 | $75 |
| Omeprazole | 114 | $1,406 | $12 |
| Hydrocodone-Acetaminophen | 77 | $1,351 | $18 |
| Ventolin Hfa | 21 | $1,239 | $59 |
| Bd Ultra-Fine Pen Needle | 18 | $1,189 | $66 |
| Toprol Xl | 16 | $1,085 | $68 |
| Metoprolol | 32 | $1,085 | $34 |
| Duloxetine | 22 | $1,049 | $48 |
| Pravastatin | 37 | $985 | $27 |
| Chlorthalidone | 16 | $980 | $61 |
| Lisinopril | 145 | $878 | $6 |
| Bumetanide | 12 | $836 | $70 |
| Verapamil Er | 11 | $784 | $71 |
| Simvastatin | 81 | $770 | $10 |
| Oxybutynin Chloride | 21 | $698 | $33 |
| Clotrimazole-Betamethasone | 16 | $692 | $43 |
| Warfarin | 42 | $688 | $16 |
| Tamsulosin | 20 | $687 | $34 |
| Clopidogrel | 26 | $626 | $24 |
| Nifedical Xl | 11 | $531 | $48 |
| Nystop | 11 | $511 | $46 |
| Synthroid | 39 | $497 | $13 |
| Valsartan-Hydrochlorothiazide | 18 | $470 | $26 |
| Hydralazine | 21 | $469 | $22 |
| Metformin | 81 | $457 | $6 |
| Metoprolol | 73 | $456 | $6 |
| Doxazosin Mesylate | 11 | $450 | $41 |
| Acetaminophen-Codeine | 31 | $443 | $14 |
| Tizanidine | 18 | $433 | $24 |
| Amlodipine Besylate | 58 | $432 | $7 |
| Alprazolam | 50 | $378 | $8 |
| Ranitidine | 24 | $377 | $16 |
| Losartan | 20 | $374 | $19 |
| Fluticasone Propionate | 30 | $367 | $12 |
| Isosorbide Mononitrate Er | 23 | $353 | $15 |
| Tramadol | 82 | $341 | $4 |
| Cyclobenzaprine | 19 | $334 | $18 |
| Montelukast | 18 | $325 | $18 |
| Oxycodone-Acetaminophen | 12 | $304 | $25 |
| Furosemide | 86 | $290 | $3 |
| Sertraline | 23 | $289 | $13 |
| Methylprednisolone | 14 | $257 | $18 |
| Hydrochlorothiazide | 38 | $255 | $7 |
| Meclizine | 13 | $250 | $19 |
| Prednisone | 51 | $242 | $5 |
| Lorazepam | 29 | $214 | $7 |
| Paroxetine | 12 | $211 | $18 |
| Pantoprazole | 12 | $209 | $17 |
| Enalapril Maleate | 11 | $189 | $17 |
| Azithromycin | 32 | $169 | $5 |
| Triamcinolone Acetonide | 14 | $158 | $11 |
| Glimepiride | 12 | $139 | $12 |
| Trazodone | 14 | $138 | $10 |
| Donepezil | 15 | $138 | $9 |
| Meloxicam | 15 | $98 | $7 |
| Carvedilol | 20 | $96 | $5 |
| Temazepam | 16 | $89 | $6 |
| Ciprofloxacin | 11 | $88 | $8 |
| Atenolol | 14 | $78 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $73 | $7 |
| Glipizide | 16 | $64 | $4 |
| Clonazepam | 14 | $48 | $3 |
| Cephalexin | 11 | $31 | $3 |
2014: 30 drugs
| Spiriva | 20 | $7,936 | $397 |
| Nexium | 16 | $6,904 | $431 |
| Lantus Solostar | 17 | $6,425 | $378 |
| Symbicort | 13 | $3,363 | $259 |
| Proair Hfa | 25 | $1,622 | $65 |
| Bd Ultra-Fine Pen Needle | 18 | $1,200 | $67 |
| Hydrocodone-Acetaminophen | 44 | $930 | $21 |
| Gabapentin | 22 | $881 | $40 |
| Atorvastatin | 53 | $699 | $13 |
| Omeprazole | 46 | $590 | $13 |
| Metoprolol | 11 | $421 | $38 |
| Levothyroxine | 19 | $382 | $20 |
| Fluticasone Propionate | 17 | $310 | $18 |
| Lisinopril | 39 | $293 | $8 |
| Clopidogrel | 13 | $268 | $21 |
| Levofloxacin | 11 | $234 | $21 |
| Synthroid | 11 | $210 | $19 |
| Warfarin | 20 | $205 | $10 |
| Tramadol | 28 | $172 | $6 |
| Metformin | 21 | $168 | $8 |
| Naproxen | 14 | $163 | $12 |
| Simvastatin | 26 | $154 | $6 |
| Acetaminophen-Codeine | 14 | $146 | $10 |
| Metoprolol | 30 | $129 | $4 |
| Hydrochlorothiazide | 18 | $115 | $6 |
| Amlodipine Besylate | 14 | $105 | $7 |
| Alprazolam | 22 | $101 | $5 |
| Sertraline | 12 | $100 | $8 |
| Furosemide | 22 | $76 | $3 |
| Prednisone | 12 | $52 | $4 |
2013: 17 drugs
| Lantus Solostar | 23 | $12,144 | $528 |
| Nexium | 15 | $6,986 | $466 |
| Advair Diskus | 14 | $4,142 | $296 |
| Bd Ultra-Fine Pen Needle | 21 | $787 | $37 |
| Gabapentin | 12 | $344 | $29 |
| Klor-Con M20 | 14 | $290 | $21 |
| Atorvastatin | 15 | $270 | $18 |
| Losartan | 13 | $213 | $16 |
| Omeprazole | 20 | $201 | $10 |
| Levothyroxine | 21 | $158 | $8 |
| Metformin | 21 | $151 | $7 |
| Hydrochlorothiazide | 14 | $131 | $9 |
| Lisinopril | 24 | $130 | $5 |
| Carvedilol | 13 | $111 | $9 |
| Simvastatin | 14 | $105 | $8 |
| Trazodone | 11 | $57 | $5 |
| Ranitidine | 11 | $56 | $5 |
Money from drug and device companies
$27 in 2025
A payment is not proof that care is biased.
| Lilly USA | Zepbound | $27 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2025-05-27 | Zepbound | $27 |
Professional record
- NPI
- 1932495777
- Licence
- CA A147104California A147104: Current · expires 2027-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 1 Embarcadero Ctr Ste 1900, San Francisco, CA, 94111
- NPI first listed
- 2011-06-20
- NPI last updated
- 2025-06-30
- NPI record certified
- 2025-06-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 325 Sharon Park Dr Ste F3, Menlo Park, CA, 94025 · 746 the Alameda Ste 10, San Jose, CA, 95126